LOX-1, Oxidative Stress and Inflammation: A Novel Mechanism for Diabetic Cardiovascular Complications

The Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 and its Soluble Form: Cardiovascular Implications

(2011) Teresa Navarra et al.   Journal of Atherosclerosis and Thrombosis

Oxidized high-density lipoprotein enhances inflammatory activity in rat mesangial cells

(2010) Miao Zhang et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Antiangiogenic and Antimitotic Effects of Aspirin in Hypoxia–Reoxygenation Modulation of the LOX-1-NADPH Oxidase Axis as a Potential Mechanism

(2010) Magomed Khaidakov et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Apigenin inhibits tumor necrosis factor alpha plus high glucose-induced LOX-1 expression in human endothelial cells

(2010) Kazuo Yamagata et al.   MICROVASCULAR RESEARCH

Treatment of the post-ischaemic inflammatory syndrome of diabetic nephropathy

(2010) K.J. Kelly et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Statins and angiogenesis: Is it about connections?

(2009) Magomed Khaidakov et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

LOX-1

(2009) Sayoko Ogura et al.   CIRCULATION JOURNAL

Effect of apocynin on NADPH oxidase-mediated oxidative stress-LOX-1-eNOS pathway in human endothelial cells exposed to high glucose

(2009) Ashraf Taye et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Lectin-Like Oxidized LDL Receptor-1 (LOX-1) Expression in the Tubulointerstitial Area Likely Plays an Important Role in Human Diabetic Nephropathy

(2009) Naoyuki Yamamoto et al.   INTERNAL MEDICINE

Deletion of LOX-1 attenuates renal injury following angiotensin II infusion

(2009) Changping Hu et al.   KIDNEY INTERNATIONAL

Downregulation of Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 After Ischemic Preconditioning in Ischemia-Reperfused Rat Kidneys

(2009) Yoji Hyodo et al.   UROLOGY

Glycoxidized LDL increases lectin-like oxidized low density lipoprotein receptor-1 in diabetes mellitus

(2008) Sammy W.M. Shiu et al.   ATHEROSCLEROSIS

The oral anti-diabetic agent, gliclazide, inhibits oxidized LDL-mediated LOX-1 expression, metalloproteinase-9 secretion and apoptosis in human aortic endothelial cells

(2008) Ling Li et al.   ATHEROSCLEROSIS

Advanced glycation end products serve as ligands for lectin-like oxidized low-density lipoprotein receptor-1(LOX-1): biochemical and binding characterizations assay

(2008) Xiuping Chen et al.   CELL BIOCHEMISTRY AND FUNCTION

Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 correlates with oxidative stress markers in stable coronary artery disease

(2008) Fumihiko Kamezaki et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Soluble lectin-like oxidized low density lipoprotein receptor-1 in type 2 diabetes mellitus

(2008) Kathryn C. B. Tan et al.   JOURNAL OF LIPID RESEARCH

Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies

(2008) Theodore Mazzone et al.   LANCET

Elevated Soluble Lectin-like Oxidized LDL Receptor-1 (sLOX-1) Levels in Obese Postmenopausal Women

(2008) Tina E. Brinkley et al.   Obesity

The Protective Effects of Taurine against Early Renal Injury in STZ-Induced Diabetic Rats, Correlated with Inhibition of Renal LOX-1-Mediated ICAM-1 Expression

(2008) Lijun Wang et al.   RENAL FAILURE

Diabetic complications and dysregulated innate immunity

(2007) Dana et al.   Frontiers in Bioscience-Landmark

LOX-1 abrogation reduces myocardial ischemia–reperfusion injury in mice

(2007) Changping Hu et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY